In the wake of COVID-19 pandemic taking massive toll globally, Bangladesh Corporate Giant Beximco Group decided to provide Personal Protective Equipment (PPE), medicines, test kits for diagnosis for protecting the front-line health care workers.
Beximco Group’s pharmaceutical division, Beximco Pharma, has started distributing these equipment to protect the healthcare professionals in the country.
Nazmul Hassan MP, Managing Director, Beximco Pharma, handed over the first consignment of the equipment to representatives from different testing centres and Government designated hospitals for treating COVID-19 patients. He handed over them during a simple ceremony at a local hotel today on 28 March.
Ms. Mia Seppo, UN Resident Coordinator in Bangladesh, Prof. Allen Ross, Senior Director, Infectious Diseases Division of icddr,b, Dr Bardan Jung Rana, WHO Representative in Bangladesh, Dr. Michael Friedman, Country Director, CDC, Prof. Dr. Meerjady Sabrina Flora, Director, IEDCR, and Prof Dr. Ahmedul Kabir, General Secretary, Bangladesh Society of Medicine were also present on this occasion.
Beximco Group has contributed BDT15 crore (US$1.8 million) to support this initiative.
Beximco Group Chairman A S F Rahman said, “As the spread of COVID-19 accelerates, affecting almost every country around the world, we are also facing an unprecedented challenge to cope with the impact of this pandemic.”
“Ensuring access to personal protective equipment is a top priority right now, and we are proud to be responding to this need to ensure the safety of healthcare professionals in Bangladesh. We, as a responsible business group, will continue to provide our wholehearted support to the Government in facing this enormous crisis,” said ASF Rahman.
Bangladesh has so far reported 48 cases of COVID-19 and 5 deaths, with a number people suspected of having COVID-19 under quarantine.
Managing Director, Beximco Pharma Nazmul Hassan MP, said, “Beximco will continue to provide essential PPE in order to ensure the safety of the doctors, nurses, and patients and help to maintain normal hospital activity as much as possible. In addition, Beximco Pharma is actively involved in various initiatives and support programmes in response to the COVID-19 outbreak.”
In the first phase, the Company will distribute sufficient numbers of PPE to two testing centres – IEDCR and icddr,b, and other Government designated hospitals for COVID-19 treatment namely Kuwait Maitri Hospital, Kurmitola General Hospital, Bangladesh Railway Hospital in Kamlapur, Mahanagar General Hospital in Nayabazar, BAVS Maternity Hospital in Mirpur, Kamrangirchar 31-bed Hospital, Aminbazar 20-bed Hospital, Jinjira 20-bed Hospital and CMH Dhaka.
In the second phase Beximco Pharma will expand distribution of these PPE nationwide to more than 150 leading hospitals.